臨床眼科74巻10号

2020年10月発行

連載 今月の話題

新型コロナウイルスに生じる結膜炎の臨床所見—既報のまとめ

著者： 佐々木香る¹

所属機関： ¹関西医科大学眼科学教室

ページ範囲：P.1187 - P.1199

　2020年，水様性眼脂の結膜炎患者が来院するたびに新型コロナウイルス感染症（COVID-19）の可能性を考えなければならなくなった。無症候でさえ感染予防が必要だといわれる。身近では誰もが知らず，成書にも載っていない疾患である。ともかく，イメージを得るために既報から写真で学びたいと思う。本稿では，COVID-19患者に生じた眼所見に関する論文のうち，症例写真が掲載されたものを，その論文要旨とともにレビューする。

参考文献

1）Seah I, Agrawa R：Can the coronavirus disease 2019（COVID-19）affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm 28：391-395, 2020

2）Seah IYJ, Anderson DE, Kang AEZ et al：Assessing viral shedding and infectivity of tears in coronavirus disease 2019（COVID-19）patients. Ophthalmology 127：977-979, 2020

3）Xia J, Tong J, Liu M et al：Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 92：589-594, 2020

4）Nishiura H, Kobayashi T, Miyama T et al：Estimation of the asymptomatic ratio of novel coronavirus infections（COVID-19）. Int J Infect Dis 94：154-155, 2020

5）Hu K, Patel J, Patel BC：Ophthalmic Manifestations of Coronavirus（COVID-19）. In：StatPearls［Internet］. Treasure Island（FL）：StatPearls Publishing, 2020

6）Amesty MA, Alió Del Barrio JL, Alió JL：COVID-19 disease and ophthalmology：an update. Ophthalmol Ther. doi：10.1007/s40123-020-00260-y, 2020

7）Sun X, Zhang X, Chen X et al：The infection evidence of SARS-COV-2 in ocular surface：a single-center cross-sectional study. mieRxiv. doi：https://doi.org/10.1101/2020.02.26.20027938, 2020

8）Willcox MD, Walsh K, Nichols JJ et al：The ocular surface, coronaviruses and COVID-19. Clin Exp Optom 103：418-424, 2020

9）Guo D, Xia J, Shen Y et al：SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva. J Med Virol. doi：10.1002/jmv.25856, 2020

10）Karimi S, Arabi A, Shahraki T et al：Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye（Lond） 34：1220-1223, 2020

11）Ulhaq ZS, Soraya GV：The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch Clin Exp Ophthalmol 258：1351-1352, 2020

12）Napoli PE, Nioi M, d'Aloja E et al：The ocular surface and the coronavirus disease 2019：does a dual ‘Ocular Route’ exist? J Clin Med. doi：10.3390/jcm9051269, 2020

13）Aiello F, Afflitto GG, Mancino R et al：Coronavirus disease 2019（SARS-CoV-2）and colonization of ocular tissues and secretions：a systematic review. Eye（Lond） 34：1206-1211, 2020

14）Mungmungpuntipantip R, Wiwanitkit V：Ocular manifestation, eye protection, and COVID-19. Graefes Arch Clin Exp Ophthalmol. doi：10.1007/s00417-020-04662-3, 2020

15）Chen L, Liu M, Zhang Z et al：Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol 104：748-751, 2020

16）Zhang X, Chen X, Chen L et al：The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf 18：360-362, 2020

17）Sun X, Zhang X, Chen X et al：The infection evidence of SARS-COV-2 in ocular surface：a single-center cross-sectional study. medRxiv. doi：https://doi.org/10.1101/2020/02/26/20027938, 2020

18）Cheema M, Aghazadeh H, Nazarali S et al：Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019（COVID-19）. Can J Ophthalmol. doi：10.1016/j.jcjo.2020.03.003, 2020

19）Wu P, Liang L, Chen C et al：A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis. Graefes Arch Clin Exp Ophthalmol 258：1565-1566, 2020

20）Chiotos K, Bassiri H, Behrens E et al：Multisystem inflammatory syndrome in children during the coronavirus 2019 Pandemic：A case series. Case Reports J Pediatric Infect Dis Soc 9：393-398, 2020

21）Rauf A, Vijayan A, John ST et al：Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic. Indian J Pediatr. doi：10.1007/s12098-020-03357-1, 2020

22）Valente P, Iarossi G, Federici M et al：Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019：a preliminary report. J AAPOS. doi：10.1016/j.jaapos.2020.05.002, 2020

23）Khavandi S, Tabibzadeh E, Naderan M et al：Corona virus disease-19（COVID-19）presenting as conjunctivitis：atypically high-risk during a pandemic. Cont Lens Anterior Eye 43：211-212, 2020

24）Casalino G, Monaco G, Plinio Di Sarro P et al：Coronavirus disease 2019 presenting with conjunctivitis as the first symptom. Eye（Lond） 34：1235-1236, 2020

25）Scalinci SZ, Trovato Battagliola E：Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. doi：10.1016/j.idcr.2020.e00774, 2020

26）Chen L, Deng C, Chen X et al：Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China：a cross-sectional study. Acta Ophthalmol. doi：10.1111/aos.14472, 2020

27）Daruich A, Martin D, Bremond-Gignac D：Ocular manifestation as first sign of coronavirus disease 2019（COVID-19）：interest of telemedicine during the pandemic context. Case Reports J Fr Ophtalmol 43：389-391, 2020

28）Wu P, Duan F, Luo C et al：Characteristics of ocular findings of patients with coronavirus disease 2019（COVID-19）in Hubei province, China. JAMA Ophthalmol 138：575-578, 2020

29）Ceran BB, Ozates S：Oular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol. doi：10.1007/s00417-020-04777-7, 2020

30）Deng W, Bao L, Gao H et al：Rhesus macaques can be effectively infected with SARS-CoV-2 via ocular conjunctival route. bioRxiv. Preprint. doi：https://doi.org/10.1101/2020.03.13.990036, 2020

31）Colavita F, Lapa D, Carletti F et al：SARS-CoV-2 Isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med 173：242-243, 2020

32）Guan WJ, Ni ZY, Hu Y. China Medical Treatment Expert Group for Covid-19：Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382：1708-1720, 2020

33）Loffredo L, Pacella F, Pacella E et al：Conjunctivitis and COVID-19：a meta-analysis. J Med Virol. doi：10.1002/jmv.25938, 2020

34）Liu M, Dai C, Lv X et al：Letter to the Editor：Are severe COVID-19 patients more susceptible to conjunctivitis? J Med Virol. doi：10.1002/jmv.26084, 2020

35）Lu CW, Liu XF, Jia ZF：2019-nCoV transmission through the ocular surface must not be ignored. Lancet. doi：10.1016/S0140-6736(20)30313-5, 2020

36）Hoehl S, Rabenau H, Berger A et al：Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N Engl J Med 382：1278-1280, 2020

37）Liang L, Wu P：There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. doi：10.1111/aos.14413, 2020

38）Zhou Y, Duan C, Zeng Y et al：Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology 127：982-983, 2020

39）Kumar K, Prakash AA, Gangasagara SB et al：Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients. Indian J Ophthalmol 68：1015-1017, 2020

40）Sun CB, Wang YY, Liu GH et al：Role of the eye in transmitting human coronavirus：what we know and what we do not know. Front Public Health. doi：10.3389/fpubh.2020.00155, 2020

41）Qing H, Li Z, Yang Z et al：The possibility of COVID-19 transmission from eye to nose. Acta Ophthalmol. doi：10.1111/aos.14412, 2020

42）Peng Y, Zhou YH：Is novel coronavirus disease（COVID-19）transmitted through conjunctiva? J Med Virol. doi：10.1002/jmv.25753, 2020

43）Wan Y, Shang J, Graham R et al：Receptor Recognition by the Novel Coronavirus from Wuhan：an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. doi：10.1128/JVI.00127-20, 2020

44）Hoffmann M, Kleine-Weber H, Schroeder S et al：SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181：271-280, 2020

45）Sungnak W, Huang N, Bécavin C et al：SARS-CoV-2 entry genes are most highly expressed in nasal goblet and ciliated cells within human airways. ArXiv arXiv：2003.06122v1. Preprint. 2020

46）Zhou P, Yang XL, Wang XG et al：A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579：270-273, 2020

47）Marinho PM, Marcos AAA, Romano AC et al：Retinal findings in patients with COVID-19. Lancet. doi：10.1016/S0140-6736(20)31014-X, 2020

48）Wang Y, Detrick B, Yu ZX et al：The role of apoptosis within the retina of coronavirus-infected mice. Invest Ophthalmol Vis Sci 41：3011-3119, 2000

49）Navel V, Chiambaretta F, Dutheil F：Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am J Ophthalmol Case Rep. doi：10.1016/j.ajoc.2020.100735, 2020

50）Neri P, Lamperti M, Pichi F：SARS-COV-2 and eye immunity：the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models. Int Ophthalmol 40：1879-1883, 2020

51）Hooper LC, Chin MS, Detrick B et al：Retinal degeneration in experimental coronavirus retinopathy（ECOR）is associated with increased TNF-alpha, soluble TNFR2 and altered TNF-alpha signaling. J Neuroimmunol 166：65-74, 2005

52）Güemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A et al：SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis. J Infect. doi：10.1016/j.jinf.2020.05.070, 2020

53）Scheer L, Hillsgrove R：Urgent and emergent eye care strategies to protect against COVID-19. Fed Pract 37：220-223, 2020

54）Bacherini D, Biagini I, Lenzetti C et al：The COVID-19 pandemic from an ophthalmologist's perspective. Trends Mol Med 26：529-531, 2020

55）Safadi K, Kruger JM, Chowers I et al：Ophthalmology practice during the COVID-19 pandemic. BMJ Open Ophthalmol. doi：10.1136/bmjophth-2020-000487, 2020

56）Lai 1THT, Tang EWH, Chau SKY et al：Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak：an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol 258：1049-1055, 2020

57）白根雅子・高須賀重信・前田利根・他：【新型コロナウイルス感染症情報】眼科診療に係る新型コロナウイルス感染症Q & A．日本の眼科91：467-487，2020

58）Shetty R, Jayadev C, Chabra A et al：Sanitizer aerosol-driven ocular surface disease（SADOSD）-A COVID-19 repercussion? Indian J Ophthalmol 68：981-983, 2020

59）土至田宏・前田直文：新型コロナウイルス感染症流行時のコンタクトレンズに関する対応策．日コレ誌61（in press）